Epaderm ointment in children with eczema

Not Applicable

Withdrawn

• Conditions: eczema; Skin - Dermatological conditions

• Registration Number: ACTRN12615001343594
• Lead Sponsor: Capital and Coast District Health board

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-12-09
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Withdrawn
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

a) Eczema with a severity on SCORAD of greater or equal to 5 for objective measures only
b) Children with eczema aged 0-5
c) Parent/caregiver must be able to speak enough English to understand the trial and be able to complete the trial diary

Exclusion Criteria

a) Other serious chronic disease that may require immunosuppressive therapy, as decided on a case by case basis by the principal investigator.
b) Use of systemic antibacterial therapy within one week prior to starting study treatment
c) Patients with co-morbid conditions that would require long term systemic corticosteroid therapy during study treatment. Systemic steroid use for less or equal to 5 days for another reason such as asthma is permissible.
d) Severe eczema requiring regular use of potent topical steroids
e) Family unable to comply with study requirements as judged by the investigator, such as the desire to use other non-study eczema medications unless medically indicated
f) Use of potent topical steroids within one month of enrolment (e.g. mometasone, betamethasone, fluticasone, clobetasol)

Study & Design

• Study Type: Interventional
• Study Design: Not specified